ResearchMoz

Global and China Monoclonal Antibody Industry Report, 2013 - 2017

Research In China
Published Date » 2013-12-23
No. Of Pages » 118
 Currently, monoclonal antibody agents have been successfully used in the treatment of tumors, cancers and other serious diseases as a heavyweight in the biopharmaceutical industry. In 2009-2012, the market size of monoclonal antibody agents grew at a CAGR of 13%, far higher than the overall growth rate of biopharmaceuticals in the same period. Thanks to robust market demand, approval of new products and new indications as well as launch of monoclonal antibody generic drugs, the global monoclonal antibody market size will ascend by more than 12% in 2013-2017, hitting USD141 billion in 2017. 
   
 Driven by enhanced economic level, expanded scope of medical insurance reimbursement, as well as lower prices incurred by intensified competition, Chinese monoclonal antibody market is...
Table of Content

1 Overview of Monoclonal Antibody Industry
1.1 Definition
1.2 Classification
1.3 Technological Development

2 Overview of Global Monoclonal Antibody Industry 
2.1 Status Quo 
2.2 Market Size 
2.3 Competition Pattern 
2.4 Development Prospect and Prediction
2.4.1 Market Size 
2.4.2 Competition Pattern 
2.4.3 R & D Trend 

3 Chinese Monoclonal Antibody Market 
3.1 Status Quo 
3.2 Market Size 
3.3 Market Segments
3.3.1 Rituximab/Rituxan
3.3.2 Trastuzumab/Herceptin
3.3.3 Cetuximab/Erbitux
3.3.4 Nimotuzumab/Infilixmab
3.3.5 Bevacizumab
3.3.6 Recombinant Human Tumor Necrosis Factor Receptor Type II - Antibody Fusion Protein
3.4 Competition Pattern 
3.5 Development Prospect 

4 Key Foreign Monoclonal Antibody Agent Enterprises
4.1 Roche Pharmaceuticals
4.1.1 Profile
4.1.2 Operation 
4.1.3 Revenue Structure 
4.1.4 R & D and Investment
4.1.5 Monoclonal Antibody Business (Genentech) 
4.1.6 Business in China 
4.2 Johnson & Johnson 
4.2.1 Profile
4.2.2 Operation 
4.2.3 Revenue Structure 
4.2.4 R & D and Investment
4.2.5 Monoclonal Antibody Business 
4.2.6 Business in China 
4.3 Merck 
4.3.1 Profile
4.3.2 Operation 
4.3.3 Revenue Structure 
4.3.4 R & D and Investment
4.3.5 Monoclonal Antibody Business 
4.3.6 Business in China 
4.4 NVS 
4.4.1 Profile
4.4.2 Operation 
4.4.3 Revenue Structure 
4.4.4 R & D and Investment
4.4.5 Monoclonal Antibody Business 
4.4.6 Business in China 
4.5 AbbVie
4.5.1 Profile
4.5.2 Revenue Structure 
4.5.3 R & D and Investment 
4.5.4 Monoclonal Antibody Business 
4.5.5 Business in China 
4.6 Amgen 
4.6.1 Profile
4.6.2 Operation 
4.6.3 Revenue Structure 
4.6.4 R & D and Investment
4.6.5 Monoclonal Antibody Business 
4.6.6 Business in China 

5 Key Chinese Monoclonal Antibody Agent Enterprises
5.1 Shanghai Lansheng States Kin Pharmaceutical Co., Ltd. 
5.1.1 Profile
5.1.2 Shanghai CP Guojian Pharmaceutical Co., Ltd.
5.1.3 Shanghai Zhangjiang Biotech Co., Ltd. 
5.1.4 Shanghai CP GuoJian Biotech Academy
5.1.5 Shanghai Guosheng Pharmaceutical Co., Ltd. 
5.2 Beijing Biotech Pharmaceutical Co., Ltd.
5.2.1 Profile
5.2.2 Competitive Edges
5.2.3 Development Prospect 
5.3 Chengdu Huasun Group Co., Ltd.
5.3.1 Profile
5.3.2 Chengdu Huasun Biotech Co., Ltd.
5.4 Shanghai Medipharm Biotech Co., Ltd.
5.4.1 Profile
5.4.2 Monoclonal Antibody Business 
5.5 Zhejiang Hisun Pharmaceutical Co., Ltd.
5.5.1 Profile
5.5.2 Monoclonal Antibody Business 
5.6 Yunnan Walvax Biotechnology Co., Ltd.
5.6.1 Profile
5.6.2 Monoclonal Antibody Business 
5.7 Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
5.7.1 Profile
5.7.2 Monoclonal Antibody Business 
5.8 Beijing SL Pharmaceutical Co., Ltd.
5.8.1 Profile
5.8.2 Monoclonal Antibody Business 
5.9 Shenzhen Main Luck Pharmaceuticals Inc.
5.9.1 Profile
5.9.2 Monoclonal Antibody Business 
5.10 Huahai Pharmaceutical Co., Ltd.
5.10.1 Profile
5.10.2 Monoclonal Antibody Business 

6 Summary and Forecast
6.1 Comparison between Domestic and Foreign Companies
6.2 Market Forecast

List of Tables


List of Figures

Upcoming Reports:

Cognitive Assessment And Training Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019
By - Transparency Market Research
Cognitive assessment and training is a formal assessment of one’s psychological functions and speed of information processing. This method of assessment helps an individual in assessing, defining and focusing on individual needs more efficiently. The analysis after cognitive assessment can be useful for various functions such as cognitive training of individuals, early detection of dementia among population and sports management. Based on the statistics provided by Alzheimer's Disease International, approximately 44.4 million people are suffering from dementia worldwide, as of 2013;...
Fermenters Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
By - Transparency Market Research
Fermenters are used for a variety of fermentation processes performed for pharmaceuticals drug manufacturing. The fermentation process includes the growth of bacteria and production of drugs under tight regulations such as aeration rate, dosage of nutrients and temperature control. Fermenters are equipments that support the cell culture at a large scale. These are maintained at certain temperature, humidity, pressure and other environmental parameters. They are constituted of various parts that help to maintain numerous environmental parameters. These parts include motor, pH...
Angina Pectoris Market - Global Industry Size, Market Share, Trends, Analysis And Forecasts 2012 - 2018
By - Transparency Market Research
Angina pectoris market is expected to grow at the CAGR of 3.5% and reach the value of $12,707.4 million by the year 2018. This growth is primarily driven by the increase in number of patients undergoing treatment for angina pectoris and likely approval of new therapies like varespladib and Generx that are in late stage of clinical development. If approved, these products are expected to contribute in the growth of angina pectoris industry as they will be marketed at premium price by their inventor companies. Innovative mechanism of action of these products will lead to...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.us
Select License type:

Share this report

Related News

Typhoon Rammasun hits Yangjiang, Guangdong province
Jul 22, 2014  
The largest typhoon to hit the southern part of China in forty years has resulted in death of 17 people after wreaking havoc on Philippines. The typhoon Rammasun has resulted in deaths of eight people on the island of Hainan. Many people are recorded missing and nine of these from the Guangxi region. This typhoon caused landfall on Friday, and was reported with winds exceeding 200...
Allergan to Slash 1,500 Jobs Amid Fighting Valeant Bid
Jul 22, 2014  
Allergan, best known as the maker of Botox, has announced plans to slash 13% of its workforce, which means that 1,500 employees will be facing the axe. Allergan said that the massive layoffs are in an effort to make the company more productive and efficient. The company, based in Irvine, California, said Monday that nearly 250 vacant positions will be eliminated as part of this...
Netflix Surpasses Projected Earnings in Second Quarter of 2014 with Double the Profits
Jul 22, 2014  
Netflix, the internet video services provider, has reported that its earnings in the second quarter more than doubled. The company attributed this spike in earnings to the success of new episodes from one of its highly successful series. This has helped Netflix’s customer base to reach higher than 50 million worldwide – highest ever in the company’s history. The...
Oil deal between China and Venezuela
Jul 22, 2014  
Venezuela and China have come together and signed mineral and oil deals. Some very significant deals with Brazil and Argentina have already been signed by Mr. Xi Jinping, the Chinese president. The next country, with which he will sign a deal with, is Cuba.  Mr. Xi has agreed to pay a currency swap valued at USD 11 billion to Argentina and this will fulfill the requirement of funds...
Deadly plague hits Western U.S. state, four cases identified
Jul 21, 2014  
The deadly plague that was reported in Colorado last week, has affected three more people in the state, taking the number to a total of four cases. The pneumonic plague has been stated to be the deadliest detected in the state in a decade. While the man originally infected with the plague has been hospitalized, two of the new cases have also confirmed the infection and the third new case is a...